Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Shorts are down today to 18,000 from just over 40,000.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1677)
•••
Comment by DJDawgon Mar 21, 2023 11:21am
208 Views
Post# 35351262

RE:RE:RE:Shorts are down today to 18,000 from just over 40,000.

RE:RE:RE:Shorts are down today to 18,000 from just over 40,000.
Recall that they are allowed to have a pre-meeting to discuss BTD during which they get feedback on the merits of the application. So could have recieved direction in that regard at that meeting. The biggest thing that could have come from it would be a stated preference for a larger sample size. Which takes time.

I'm not sure how much the price fluctations can be from anyone with inside knowledge ad the company is a small size with almost all the insiders holding large volume of shares that they are not allowed to sell secretly. Has to be openly disclosed.

My hunch is that there are some whose day trading jobs is to find companies that are in information limbo and work on swing trades back and forth.

I truly look forward to the day when someone wants a larger volume buy in and none have us are wiling to sell. That would be in an impressive spike when that happens.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities